Table 6.

Association of IL-1β and POSG treatment with HAM-A results.

	β	Error SD	p	OR (minimum-maximum)
POSG vs. PCG	-0.33	0.11	<0.01∗	0.68 (0.40; 1.15)
POSG vs. PCG in IL-1β rs16944 noncarriers	-0.29	0.19	0.12	0.75 (0.52; 1.08)
POSG vs. PCG in IL-1β rs16944 A carriers	-0.32	0.13	0.02∗	0.73 (0.56; 0.94)

HAM-A results associated with polymorphism rs16944 within the IL-1β gene with 12 weeks in the psychobiotic oral suspension group (POSG). GEE analysis for HAM-A results, significant values (^∗p ≤ 0.05) are expressed for POSG vs. placebo control group (PCG), POSG vs. PCG in IL-1β rs16944 noncarrier group, and POSG vs. PCG in IL-1β rs16944 carrier group.